Rabies Virus, Kv

Verify with FDA CVM →

2,080 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
2,080
Total Reports
268
Deaths Reported
1290.0%
Death Rate

Active Ingredients

Rabies Virus, Kv

Administration Routes

SubcutaneousUnknownIntramuscularOralSubconjunctivalNasal

Species Affected

Dog 1,776
Cat 303
Human 1

Most Affected Breeds

Domestic Shorthair 201
Terrier - Bull - American Pit 141
Retriever - Labrador 128
Chihuahua 111
Terrier - Yorkshire 81
Boxer (German Boxer) 69
Shih Tzu 68
Dachshund (unspecified) 62
Crossbred Canine/dog 56
Retriever - Golden 55

Most Reported Reactions

Vomiting 695
Lethargy (see also Central nervous system depression in 'Neurological') 306
Diarrhoea 275
Lethargy (see also Central nervous system depression in Neurological) 269
Anaphylaxis 257
Facial swelling (see also 'Skin') 246
Fever 205
Facial swelling (see also Skin) 196
Anorexia 183
Pale mucous membrane 182
Anaphylactoid reaction 165
Death 133

Outcome Breakdown

Ongoing
991 (47.6%)
Recovered/Normal
718 (34.5%)
Died
147 (7.1%)
Euthanized
121 (5.8%)
Outcome Unknown
101 (4.9%)
Recovered with Sequela
3 (0.1%)

Data Summary

Metric Value
Total adverse event reports 2,080
Reports involving death 268
Case-fatality rate (reported events) 1290.0%
Distinct species in reports 3
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Rabies Virus, Kv Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 2,080 adverse event reports referencing Rabies Virus, Kv, including 268 reports in which the animal died — a 1290.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Rabies Virus, Kv. Reported administration routes include Subcutaneous, Unknown, Intramuscular, Oral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Rabies Virus, Kv reports are Dog (1,776 reports), Cat (303 reports), Human (1 reports), with Dog accounting for the largest share. Within those species, Domestic Shorthair (201), Terrier - Bull - American Pit (141), Retriever - Labrador (128) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Rabies Virus, Kv are Vomiting (695), Lethargy (see also Central nervous system depression in 'Neurological') (306), Diarrhoea (275), Lethargy (see also Central nervous system depression in Neurological) (269). Of the 2,081 reports with a coded outcome, Ongoing is the leading category at 47.6%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Rabies Virus, Kv.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial